PET/CT影像组学评估非小细胞肺癌纵隔淋巴结转移的进展  

Progress of PET/CT radiomics in evaluating mediastinal lymph node metastasis of non-small cell lung cancer

作　　者：蒋可思 杨建峰 JIANG Kesi;YANG Jianfeng(School of Medicine,Shaoxing University,Shaoxing 312000;the First Affiliated Hospital of Shaoxing University,Shaoxing 312000,China)

机构地区：[1]绍兴文理学院医学院,浙江绍兴312000 [2]绍兴文理学院附属第一医院,浙江绍兴312000

出　　处：《临床医学研究与实践》2025年第12期195-198,共4页Clinical Research and Practice

摘　　要：非小细胞肺癌(NSCLC)是常见的恶性肿瘤,有无纵隔淋巴结转移是影响NSCLC患者预后的重要指标之一。正电子发射计算机断层成像(PET/CT)已广泛应用于NSCLC淋巴结转移的诊断与评估,但准确性偏低。随着影像组学在疾病评估中的不断成熟,基于PET/CT的影像组学评估NSCLC纵隔淋巴结转移受到越来越多的关注。本文从NSCLC原发肿瘤灶、淋巴结本身及两者结合的PET/CT影像组学开展综述,探讨^(18)F-氟代脱氧葡萄糖(^(18)F-FDG)PET/CT的影像组学在评估NSCLC淋巴结转移中的进展和应用。Non-small cell lung cancer(NSCLC)is a common malignant tumor.The presence or absence of mediastinal lymph node metastasis is one of the important indicators affecting the prognosis of NSCLC patients.Positron emission to mography and computed tomography(PET/CT)has been widely used in the diagnosis and evaluation of lymph node metastasis in NSCLC,but the accuracy is low.With the maturity of radiomics in disease assessment,PET/CT-based radiomics has attracted more and more attention in the assessment of mediastinal lymph node metastasis in NSCLC.This article reviews the PET/CT radiomics of NSCLC primary tumor,lymph node itself and the combination of the two,and discusses the progress and application of ^(18)F-fluorodeoxyglucose(^(18)F-FDG)PET/CT radiomics in NSCLC lymph node metastasis.

关 键 词：非小细胞肺癌 正电子发射计算机断层成像 淋巴结 转移 影像组学 

分 类 号：R734.2[医药卫生—肿瘤]